DBV Technologies (ADR)
Develops an investigational skin patch for peanut allergy using epicutaneous immunotherapy.
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Shares outstanding 23.92M · Float 14.54M · 60.8% free float
Insiders — filings are in the shares behind the receipt.
This listing is a depositary receipt and the Form 4 positions here are filed in the shares behind it, a different unit from the share count and in a ratio the filings never state, so no insider percentage is shown.
Institutions13F, as of Mar 31, 2026
72 holders · 21.18M shares · 30 new positions · 43 increased · 13 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Bioimpact Capital LLC | 5.21M | 21.79% | +4.22M | May 15, 2026 |
| Vivo Capital, LLC | 2.67M | 11.15% | +205.9K | May 20, 2026 |
| Artisan Partners Limited Partnership | 2.22M | 9.28% | −1.09M | May 13, 2026 |
| Siren, L.L.C. | 1.86M | 7.76% | 0 | May 14, 2026 |
| Baker Bros. Advisors LP | 1.46M | 6.11% | 0 | May 15, 2026 |
| Adar1 Capital Management, LLC | 1.01M | 4.23% | +1.01Mnew | May 18, 2026 |
| Perceptive Advisors LLC | 964.4K | 4.03% | +964.4Knew | May 29, 2026 |
| Patient Square Capital LP | 693.5K | 2.90% | +334.5K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors (GP) LLCincl. Felix J. Baker, Julian C. Baker +1 more | 17.10% | 23.49M | 13D | Mar 31, 2025 ↗ |
| Baker Bros. Advisors LP | 9.99% | 13D | Jan 14, 2026 ↗ | |
| Suvretta Capital Management, LLC | 9.90% | 15.18M | 13G | Apr 11, 2025 ↗ |
| MPM BioImpact LLC | 8.80% | 13G | May 15, 2026 ↗ | |
| Adage Capital Management, L.P. | 7.31% | 13G | May 13, 2026 ↗ | |
| Citadel Advisors LLC | 6.40% | 9.16M | 13G | Apr 14, 2025 ↗ |
| Invus Public Equities, L.P. | 6.10% | 13G | May 5, 2026 ↗ | |
| RA Capital Management, L.P. | 5.80% | 13G | Aug 6, 2026 ↗ |
InsidersForm 4
No current Form 4 position on record.
1 person has not refiled in the last 18 months (1.34M shares), so they are not in the figure above · 15 positions are filed in the unlisted share unit (18.64M shares), which no share count here divides
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 29, 2026 | Pharis Mohideenofficer: Chief Medical Officer | Sale | 464 | $2.70 | 144,531 |
| Jan 29, 2026 | Pharis Mohideenofficer: Chief Medical Officer | Sale | 534 | $4.86 | 144,995 |
| Dec 18, 2025 | Bpifrance EPICother: Member of 10% owner group | Sale | 1,292,103 | $4.19 | 7,303,369 |
| Dec 17, 2025 | Bpifrance EPICother: Member of 10% owner group | Sale · 2 lots | 2,076,990 | $4.85 | 8,595,472 |
| Nov 21, 2025 | Pharis Mohideenofficer: Chief Medical Officer | Sale | 1,624 | $2.77 | 101,529 |
| Nov 20, 2025 | Pharis Mohideenofficer: Chief Medical Officer | Sale | 6,496 | $2.88 | 103,153 |
CongressHouse and Senate disclosures
Not reported.